TrialsgrambetaRCTs are beautiful

FIT (Vertebral Fracture Arm)

1996

Fracture Intervention Trial — Vertebral Fracture Arm

In 2,027 postmenopausal women with ≥1 prevalent vertebral fracture, alendronate reduced new vertebral, clinical and hip fractures compared with placebo.

Result

Efficacy: New morphometric vertebral fractureRR 0.53

Below 1 favours alendronate, above 1 favours placebo.

Also reported: Clinical vertebral RR 0.45; hip fracture RR 0.49 (p=0.047).

Original publication
Subtopic
Bisphosphonates
Design
Double-blind RCT, 36 mo
Relevance
Practice-defining: a trial the field needs to know.
Source
Black DM, et al. Lancet. 1996;348(9041):1535-1541.doi 10.1016/S0140-6736(96)07088-2

Discussion & critique

Established bisphosphonates as first-line antifracture therapy, still the foundation of modern osteoporosis treatment.

Discussed in podcasts